397 related articles for article (PubMed ID: 31184707)
1. miRNA Profiling Reveals miRNA-130b-3p Mediates DENND1A Variant 2 Expression and Androgen Biosynthesis.
McAllister JM; Han AX; Modi BP; Teves ME; Mavodza GR; Anderson ZL; Shen T; Christenson LK; Archer KJ; Strauss JF
Endocrinology; 2019 Aug; 160(8):1964-1981. PubMed ID: 31184707
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype.
McAllister JM; Modi B; Miller BA; Biegler J; Bruggeman R; Legro RS; Strauss JF
Proc Natl Acad Sci U S A; 2014 Apr; 111(15):E1519-27. PubMed ID: 24706793
[TBL] [Abstract][Full Text] [Related]
3. The PCOS GWAS Candidate Gene
Waterbury JS; Teves ME; Gaynor A; Han AX; Mavodza G; Newell J; Strauss JF; McAllister JM
J Endocr Soc; 2022 Jul; 6(7):bvac078. PubMed ID: 35668995
[TBL] [Abstract][Full Text] [Related]
4. Human DENND1A.V2 Drives
Teves ME; Modi BP; Kulkarni R; Han AX; Marks JS; Subler MA; Windle J; Newall JM; McAllister JM; Strauss JF
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32268539
[TBL] [Abstract][Full Text] [Related]
5. Alternative splicing of DENND1A, a PCOS candidate gene, generates variant 2.
Tee MK; Speek M; Legeza B; Modi B; Teves ME; McAllister JM; Strauss JF; Miller WL
Mol Cell Endocrinol; 2016 Oct; 434():25-35. PubMed ID: 27297658
[TBL] [Abstract][Full Text] [Related]
6. Cellular and Animal Studies: Insights into Pathophysiology and Therapy of PCOS.
Indran IR; Lee BH; Yong EL
Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():12-24. PubMed ID: 27118251
[TBL] [Abstract][Full Text] [Related]
7. Colocalization of Polycystic Ovary Syndrome Candidate Gene Products in Theca Cells Suggests Novel Signaling Pathways.
Kulkarni R; Teves ME; Han AX; McAllister JM; Strauss JF
J Endocr Soc; 2019 Dec; 3(12):2204-2223. PubMed ID: 31723719
[TBL] [Abstract][Full Text] [Related]
8. Retinoids and retinol differentially regulate steroid biosynthesis in ovarian theca cells isolated from normal cycling women and women with polycystic ovary syndrome.
Wickenheisser JK; Nelson-DeGrave VL; Hendricks KL; Legro RS; Strauss JF; McAllister JM
J Clin Endocrinol Metab; 2005 Aug; 90(8):4858-65. PubMed ID: 15914525
[TBL] [Abstract][Full Text] [Related]
9. The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis.
Wood JR; Nelson VL; Ho C; Jansen E; Wang CY; Urbanek M; McAllister JM; Mosselman S; Strauss JF
J Biol Chem; 2003 Jul; 278(29):26380-90. PubMed ID: 12734205
[TBL] [Abstract][Full Text] [Related]
10. Identification of microRNAs and genes associated with hyperandrogenism in the follicular fluid of women with polycystic ovary syndrome.
Xue Y; Lv J; Xu P; Gu L; Cao J; Xu L; Xue K; Li Q
J Cell Biochem; 2018 May; 119(5):3913-3921. PubMed ID: 29193229
[TBL] [Abstract][Full Text] [Related]
11. DENND1A gene variants in Bahraini Arab women with polycystic ovary syndrome.
Gammoh E; Arekat MR; Saldhana FL; Madan S; Ebrahim BH; Almawi WY
Gene; 2015 Apr; 560(1):30-3. PubMed ID: 25626177
[TBL] [Abstract][Full Text] [Related]
12. Differential association of DENND1A genetic variants with polycystic ovary syndrome in Tunisian but not Bahraini Arab women.
Dallel M; Sarray S; Douma Z; Hachani F; Al-Ansari AK; Letaifa DB; Mahjoub T; Almawi WY
Gene; 2018 Mar; 647():79-84. PubMed ID: 29325736
[TBL] [Abstract][Full Text] [Related]
13. miR-130b regulates gap junctional intercellular communication through connexin 43 in granulosa cells from patients with polycystic ovary syndrome.
Jiang L; Huang H; Qian Y; Li Y; Chen X; Di N; Yang D
Mol Hum Reprod; 2020 Aug; 26(8):576-584. PubMed ID: 32559300
[TBL] [Abstract][Full Text] [Related]
14. Current concepts of polycystic ovary syndrome pathogenesis.
Rosenfield RL
Curr Opin Pediatr; 2020 Oct; 32(5):698-706. PubMed ID: 32889963
[TBL] [Abstract][Full Text] [Related]
15. miR-130b-3p is high-expressed in polycystic ovarian syndrome and promotes granulosa cell proliferation by targeting SMAD4.
Bao D; Li M; Zhou D; Zhuang C; Ge Z; Wei Q; Zhang L
J Steroid Biochem Mol Biol; 2021 May; 209():105844. PubMed ID: 33582305
[TBL] [Abstract][Full Text] [Related]
16. Expression of microRNA in follicular fluid in women with and without PCOS.
Butler AE; Ramachandran V; Hayat S; Dargham SR; Cunningham TK; Benurwar M; Sathyapalan T; Najafi-Shoushtari SH; Atkin SL
Sci Rep; 2019 Nov; 9(1):16306. PubMed ID: 31705013
[TBL] [Abstract][Full Text] [Related]
17. Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome.
Nelson-Degrave VL; Wickenheisser JK; Hendricks KL; Asano T; Fujishiro M; Legro RS; Kimball SR; Strauss JF; McAllister JM
Mol Endocrinol; 2005 Feb; 19(2):379-90. PubMed ID: 15514033
[TBL] [Abstract][Full Text] [Related]
18. Association analysis between the tag single nucleotide polymorphisms of DENND1A and the risk of polycystic ovary syndrome in Chinese Han women.
Zhu YN; Zhang YT; Liu Q; Shen SM; Zou X; Cao YX; Wang WJ; Yi L; Gao Q; Yang WD; Wang Y
BMC Med Genet; 2020 Jan; 21(1):14. PubMed ID: 31941453
[TBL] [Abstract][Full Text] [Related]
19. Strategies to elucidate the mechanism of excessive theca cell androgen production in PCOS.
Strauss JF; Wood JR; Christenson LK; McAllister JM
Mol Cell Endocrinol; 2002 Jan; 186(2):183-8. PubMed ID: 11900894
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of cytochrome P450 17alpha-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome.
Wickenheisser JK; Nelson-Degrave VL; McAllister JM
J Clin Endocrinol Metab; 2005 Mar; 90(3):1720-7. PubMed ID: 15598676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
